BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 26343135)

  • 1. Process Development Strategies in Plant Molecular Farming.
    Buyel JF
    Curr Pharm Biotechnol; 2015; 16(11):966-82. PubMed ID: 26343135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular farming of human cytokines and blood products from plants: challenges in biosynthesis and detection of plant-produced recombinant proteins.
    da Cunha NB; Vianna GR; da Almeida Lima T; Rech E
    Biotechnol J; 2014 Jan; 9(1):39-50. PubMed ID: 24376137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in plant molecular farming.
    Obembe OO; Popoola JO; Leelavathi S; Reddy SV
    Biotechnol Adv; 2011; 29(2):210-22. PubMed ID: 21115109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commercial aspects of pharmaceutical protein production in plants.
    Fischer R; Schillberg S; Buyel JF; Twyman RM
    Curr Pharm Des; 2013; 19(31):5471-7. PubMed ID: 23394566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic plants in the biopharmaceutical market.
    Twyman RM; Schillberg S; Fischer R
    Expert Opin Emerg Drugs; 2005 Feb; 10(1):185-218. PubMed ID: 15757412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the verge of the market - Plant factories for the automated and standardized production of biopharmaceuticals.
    Huebbers JW; Buyel JF
    Biotechnol Adv; 2021; 46():107681. PubMed ID: 33326816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plant-derived pharmaceuticals for the developing world.
    Hefferon K
    Biotechnol J; 2013 Oct; 8(10):1193-202. PubMed ID: 23857915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Target product selection - where can Molecular Pharming make the difference?
    Paul MJ; Teh AY; Twyman RM; Ma JK
    Curr Pharm Des; 2013; 19(31):5478-85. PubMed ID: 23394563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing the yield of recombinant pharmaceutical proteins in plants.
    Twyman RM; Schillberg S; Fischer R
    Curr Pharm Des; 2013; 19(31):5486-94. PubMed ID: 23394567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing product quality in molecular farming.
    Schiermeyer A
    Curr Opin Biotechnol; 2020 Feb; 61():15-20. PubMed ID: 31593785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular farming on rescue of pharma industry for next generations.
    Moustafa K; Makhzoum A; Trémouillaux-Guiller J
    Crit Rev Biotechnol; 2016 Oct; 36(5):840-50. PubMed ID: 26042351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biopharmaceuticals derived from genetically modified plants.
    Goldstein DA; Thomas JA
    QJM; 2004 Nov; 97(11):705-16. PubMed ID: 15496527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conference on plant-made pharmaceuticals. 16-19 March 2003, Québec City, Québec, Canada.
    Price B
    IDrugs; 2003 May; 6(5):442-5. PubMed ID: 12841207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plant molecular farming for the production of valuable proteins - Critical evaluation of achievements and future challenges.
    Schillberg S; Finnern R
    J Plant Physiol; 2021; 258-259():153359. PubMed ID: 33460995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering the Plant Secretory Pathway for the Production of Next-Generation Pharmaceuticals.
    Margolin EA; Strasser R; Chapman R; Williamson AL; Rybicki EP; Meyers AE
    Trends Biotechnol; 2020 Sep; 38(9):1034-1044. PubMed ID: 32818443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Green factories for biopharmaceuticals.
    Melnik S; Stoger E
    Curr Med Chem; 2013; 20(8):1038-46. PubMed ID: 23210788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient expression systems for plant-derived biopharmaceuticals.
    Komarova TV; Baschieri S; Donini M; Marusic C; Benvenuto E; Dorokhov YL
    Expert Rev Vaccines; 2010 Aug; 9(8):859-76. PubMed ID: 20673010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plant-made pharmaceuticals for the prevention and treatment of autoimmune diseases: where are we?
    Avesani L; Bortesi L; Santi L; Falorni A; Pezzotti M
    Expert Rev Vaccines; 2010 Aug; 9(8):957-69. PubMed ID: 20673017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conference scene: molecular pharming: manufacturing medicines in plants.
    Lössl AG; Clarke JL
    Immunotherapy; 2013 Jan; 5(1):9-12. PubMed ID: 23256793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharming and transgenic plants.
    Liénard D; Sourrouille C; Gomord V; Faye L
    Biotechnol Annu Rev; 2007; 13():115-47. PubMed ID: 17875476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.